Table 1 SLC12A5 expression and clinicopathological variables in bladder urothelial carcinoma
SLC12A5 expression level | ||||
|---|---|---|---|---|
Clinicopathological variables | Number of cases (n=148) | Low (%) (n=69) | High (%) (n=79) | P-valuea |
Age (years) | 0.975 | |||
⩽60b | 62 | 29 (46.8) | 33 (53.2) | |
>60 | 86 | 40 (46.5) | 46 (53.5) | |
Gender | 0.742 | |||
Male | 125 | 59 (47.2) | 66 (52.8) | |
Female | 23 | 10 (43.5) | 13 (56.5) | |
Tumor size (cm) | 0.781 | |||
⩽3.8c | 84 | 40 (47.6) | 44 (52.4) | |
>3.8 | 64 | 29 (45.3) | 35 (54.7) | |
Tumor multiplicity | 0.292 | |||
Unifocal | 39 | 21 (53.8) | 18 (46.2) | |
Multifocal | 109 | 48 (44.0) | 61 (56.0) | |
Tumor grade | 0.13 | |||
Low | 59 | 32 (54.2) | 27 (45.8) | |
High | 89 | 37 (41.6) | 52 (58.4) | |
pT status | 0.079 | |||
pT1 | 44 | 25 (56.8) | 19 (43.2) | |
pT2 | 52 | 26 (50.0) | 26 (50.0) | |
pT3/pT4 | 52 | 18 (34.6) | 34 (65.4) | |
pN status | 0.001 | |||
pN− | 123 | 65 (52.8) | 58 (47.2) | |
pN+ | 25 | 4 (16.0) | 21 (84.0) | |
